Production (Stage)
Palisade Bio, Inc.
PALI
$0.6967
$0.01642.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -100.00% | -100.00% | -100.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -100.00% | -100.00% | -100.00% |
| SG&A Expenses | -6.96% | -6.55% | -1.51% | -4.21% | -16.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.52% | 13.47% | 2.80% | 2.47% | -1.50% |
| Operating Income | 3.52% | -15.68% | -4.66% | -4.30% | -0.27% |
| Income Before Tax | 2.57% | -17.38% | -7.79% | -5.43% | -8.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.57% | -17.38% | -7.79% | -5.43% | -8.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.57% | -17.38% | -7.79% | -5.43% | -8.81% |
| EBIT | 3.52% | -15.68% | -4.66% | -4.30% | -0.27% |
| EBITDA | 3.52% | -15.69% | -4.69% | -4.32% | -0.26% |
| EPS Basic | 69.01% | 58.28% | 73.50% | 81.87% | 86.97% |
| Normalized Basic EPS | 68.50% | 57.69% | 72.99% | 80.71% | 86.56% |
| EPS Diluted | 69.01% | 58.28% | 73.53% | 81.89% | 86.97% |
| Normalized Diluted EPS | 68.50% | 57.69% | 72.99% | 80.71% | 86.56% |
| Average Basic Shares Outstanding | 320.49% | 210.37% | 210.46% | 244.62% | 360.77% |
| Average Diluted Shares Outstanding | 320.49% | 210.37% | 210.46% | 244.62% | 360.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |